Beth Cady, PharmD, BCPS


Top 5 Tips for Teaching ID Learners

The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.

William Alegria, PharmD, BCIDP


Combination Antifungal for Invasive Mucormycosis: Yay or Nay?

There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.

Alicia Bigica


Maternal COVID-19 Vaccination, Infection Boosts Infant Antibody Response

Natural infection plus COVID-19 vaccination in pregnant mothers conferred more durable antibody responses in infants than natural infection alone.

Inessa Gendlina, MD


What to Expect With Influenza in the Era of COVID-19

Here are some insights into this upcoming 2021-2022 influenza season as well as concerns of the twindemic and addressing both the seasonal and pandemic viruses simultaneously.

Judith Lee, MSN, CRNP, AACRN


HIV and Aging in the Era of Antiretroviral Therapy: Considerations in Clinical Care

With the population of adults with HIV growing older, incorporating age-based screenings, comprehensive assessments, and morbidity management into routine HIV care is essential in improving health outcomes and quality of life.

James Wilson, DO


Nonventilator Hospital-Acquired Pneumonia: Epidemiology, Prevention, and Where It Is Now

The management of hospital-acquired pneumonia requires use of preventive bundles, mitigative of risk factors, and prompt diagnosis with initiation of treatment when highly suspected.

Aiman Bandali, PharmD, AAHIVP, BCPS, BCIDP


Clinical Considerations in Conducting Antifungal Susceptibility Testing

Access to antifungal susceptibility testing (AFST) remains limited in the United States. Therefore, providers must recognize clinical situations where AFST will provide its greatest value. In the latest article from SIDP, infectious disease pharmacists offers some insights on this subject.

Zoheir Khan, MD; and Jeremy L. Agostinho, MD


A Case of Mycobacterium Chimaera Infective Endocarditis

Nonspecific, nondolent symptoms make this disease difficult to diagnose.

Leah Rodriguez, PharmD


A Review of the Currently Available Monoclonal Antibodies for COVID-19

Outside of vaccines, these underutilized therapies are the best defense against severe disease.

Society of Infectious Diseases Pharmacists


Celebrating 30 Years: The Past, Present, and Future of the Society of Infectious Diseases Pharmacists (SIDP)

Introducing “Bench to Bedside With SIDP,” a new column covering everything from antimicrobial stewardship and pharmacokinetics/pharmacodynamics to mentorship, preceptorship, and more.

Joseph Osmundson, PhD


A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect

Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.

Mustafeez Babar, PharmD, MPhil, PhD


SPREADing the Love: The Importance of Mentorship in Pharmacy

In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.

Andrew R. Motzer, MD


A Case of Varicella-Zoster Meningitis Causing Postoperative Fevers After Umbilical Hernia Repair

Due to worsening headaches and unrevealing cross-sectional imaging and ascites fluid analyses, this patient's differential evolved toward a central nervous system source.

Patrick McDaneld, PharmD, BCIDP


Are We at a Breaking Point for Adoption of Updated Susceptibility Interpretive Criteria?

The implementation of new College of American Pathologists rules presents an opportunity for collaboration between clinical microbiology laboratories and infectious disease pharmacists and physicians.

Ian Adrian F. Frani, MD, BSN


Invasive Histoplasmosis Presenting as Tenosynovitis in an Immunocompromised Patient

A patient with a history of lupus nephritis initially presented with right hand and arm symptoms that were attributed to a lupus flare. However, eight months later, the patient experienced increasing pain and edema in his right hand, leading to a diagnosis of Histoplasma tenosynovitis.

Allison Cid, PharmD


Ceftriaxone Dosing: Once or Twice Daily?

In the latest column from SIDP, clinicians discuss that along with the once-daily dosing for many indications, there are also compelling indications for twice-daily dosing.

Rachel Burgoon, PharmD


Increase in Enteroviruses Seen with Decreases in COVID-19 Precautions

The Centers for Disease Control and Prevention (CDC) reports the rise in pediatric acute respiratory illnesses especially as there is a decrease in hygiene measures that were previously employed during the pandemic.

Carl V. Crawford, MD


Looking Toward the Future of CDI Management

Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.

Monica Gandhi, MD, MPH


High-Resistance Therapy Options for Treatment-Naïve Patients With HIV

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.

Robert Bettiker, MD/MGA, FACP


Resolution of Scurvy in a Patient With a Spinal Cord Injury

At 7.1%, vitamin C deficiency in the US is rare. Unfortunately, identifying scurvy is complex, frustrating, and time-consuming for both patient and provider.

Christina Rose, PharmD, BCCCP


Oral Therapeutic Options to Prevent Disease Progression From COVID-19 in an Ambulatory Setting

As the number of COVID-19 cases continues to rise, oral treatment options for at-home use are in demand to provide early intervention and reduce the progression to severe disease, hospitalization, and death.

Katrine Wallace, PhD


Communication Breakdown: Dissemination of Public Health Information

Imprecise language can fuel infodemics and misinformation and damage public trust.

Ann-Marie Idusuyi, PharmD


Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.

Camilo Mora, PhD


When Climate Change Gets Personal: The Expanding Threat of Mosquito Habitats

As someone who lives with the long-term effects of chikungunya, Camillo Mora PhD, sees the expanding habitat of mosquitos and is concerned more people will be exposed to vector-borne illnesses and deal with not only the acute phases of these viruses but also the possibility of long-term health effects they can present.

Amy Rowley, PharmD


Unmasking the Infodemic: The Impact of COVID-19 Misinformation on Public Health

Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.

Hawra Al-Lawati, MD


Climate Change Effects on Vector-Borne Disease: The Case of Lyme

With evolving weather patterns, the natural habitat of ticks is expanding, and more people are becoming susceptible to them.

Krutika Kuppalli, MD, FIDSA; and Syra Madad, DHSc, MSc


Emerging Infectious Diseases During COVID-19

In this era of increasingly mobile and connected populations, it is possible for an infection to spread around the world in 24 to 48 hours.

© 2023 MJH Life Sciences

All rights reserved.